Corgentech is a startup based in the United States, most recent round Series-c-plus.
Corgentech is a startup based in the United States. Its most recent tracked round is Series-c-plus.
Corgentech was a US biopharmaceutical company focused on drug development for cardiovascular diseases. According to the source, Corgentech was listed on NASDAQ in 2004.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.